ILMN

Illumina

$119.26

-2.71 (-2.22%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 20.11.2025
$118.26
(-0.84%)
Strong Buy: 2
Buy: 7
Hold: 8
Sell: 1
Strong Sell: 2
Description:
Illumina, Inc. is a leading global biotechnology company based in San Diego, California, specializing in genomic analysis technologies since its founding in 1998. Renowned for its innovative sequencing, genotyping, and gene expression solutions, Illumina serves a variety of markets, including research, clinical diagnostics, and agricultural genomics, thereby significantly contributing to the advancement of personalized medicine. The company is committed to transforming human health through ongoing innovation and has established a prominent position in the genomics landscape by enabling breakthroughs in genetic research and diagnostics.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
DIAGNOSTICS & RESEARCH
Address:
5200 ILLUMINA WAY, SAN DIEGO, CA, UNITED STATES, 92122
Fiscal year end:
December
Market capitalization:
$18.7 Billion
EBITDA:
$1.17 Billion
PERatio:
27.41
EPS:
4.45
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.45

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-11%
How much will you get:
$886
Prices dates:
30-10-2015: $139.38 and 31-10-2025: $123.54